Cargando…

Second Relapse of Pediatric Patients with Acute Myeloid Leukemia: A Report on Current Treatment Strategies and Outcome of the AML-BFM Study Group

SIMPLE SUMMARY: Children with acute myeloid leukemia (AML) experience high relapse rates of about 30%; still, survival rates following the first relapse are encouraging. Hence, it is critically important to examine the consequences of a second relapse; however, little is known about this subgroup of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rasche, Mareike, Steidel, Emma, Zimmermann, Martin, Bourquin, Jean-Pierre, Boztug, Heidrun, Janotova, Iveta, Kolb, E. Anders, Lehrnbecher, Thomas, von Neuhoff, Nils, Niktoreh, Naghmeh, Mühlegger, Nora, Sramkova, Lucie, Stary, Jan, Walter, Christiane, Creutzig, Ursula, Dworzak, Michael, Reinhardt, Dirk
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7918758/ https://www.ncbi.nlm.nih.gov/pubmed/33672815 http://dx.doi.org/10.3390/cancers13040789

Ejemplares similares

Survival Following Relapse in Children with Acute Myeloid Leukemia: A Report from AML-BFM and COG
por: Rasche, Mareike, et al.
Publicado: (2021)

Improved outcome of pediatric patients with acute megakaryoblastic leukemia in the AML-BFM 04 trial
por: Schweitzer, Jana, et al.
Publicado: (2015)

Successes and challenges in the treatment of pediatric acute myeloid leukemia: a retrospective analysis of the AML-BFM trials from 1987 to 2012
por: Rasche, Mareike, et al.
Publicado: (2018)

Genotype-outcome correlations in pediatric AML: the impact of a monosomal karyotype in trial AML-BFM 2004
por: Rasche, M, et al.
Publicado: (2017)

Gemtuzumab ozogamicin in children with relapsed or refractory acute myeloid leukemia: a report by Berlin-Frankfurt-Münster study group
por: Niktoreh, Naghmeh, et al.
Publicado: (2019)

RUNX1 mutation has no prognostic significance in paediatric AML: a retrospective study of the AML-BFM study group
por: Sendker, Stephanie, et al.
Publicado: (2023)

Infectious complications in children with acute myeloid leukemia: decreased mortality in multicenter trial AML-BFM 2004
por: Bochennek, K, et al.
Publicado: (2016)

Mutated WT1, FLT3-ITD, and NUP98-NSD1 Fusion in Various Combinations Define a Poor Prognostic Group in Pediatric Acute Myeloid Leukemia
por: Niktoreh, Naghmeh, et al.
Publicado: (2019)

Antibiotic prophylaxis with teicoplanin on alternate days reduces rate of viridans sepsis and febrile neutropenia in pediatric patients with acute myeloid leukemia
por: Boztug, Heidrun, et al.
Publicado: (2016)

Development of treatment and clinical results in childhood AML in Austria (1993–2013)
por: Boztug, Heidrun, et al.
Publicado: (2014)

Phospho-Profiling Linking Biology and Clinics in Pediatric Acute Myeloid Leukemia
por: Schumich, Angela, et al.
Publicado: (2019)

Guideline for management of non-Down syndrome neonates with a myeloproliferative disease on behalf of the I-BFM AML Study Group and EWOG-MDS^
por: Bertrums, Eline J.M., et al.
Publicado: (2021)

Frequency and prognostic impact of ZEB2 H1038 and Q1072 mutations in childhood B-other acute lymphoblastic leukemia
por: Zaliova, Marketa, et al.
Publicado: (2020)

Redirecting the Immune Microenvironment in Acute Myeloid Leukemia
por: Sendker, Stephanie, et al.
Publicado: (2021)

Invasive fungal diseases impact on outcome of childhood ALL – an analysis of the international trial AIEOP-BFM ALL 2009
por: Lehrnbecher, Thomas, et al.
Publicado: (2022)

Hypodiploidy has unfavorable impact on survival in pediatric acute myeloid leukemia: an I-BFM Study Group collaboration
por: Hammer, Anne Sofie Borg, et al.
Publicado: (2022)

Impact of KMT2A Rearrangement and CSPG4 Expression in Pediatric Acute Myeloid Leukemia
por: Hoffmeister, Lina Marie, et al.
Publicado: (2021)

An R307H substitution in GATA1 that prevents Ser310 phosphorylation causes severe fetal anemia
por: Hetzer, Benjamin, et al.
Publicado: (2022)

PB1750: REARRANGEMENTS OF T-CELL RECEPTOR (TCR) LOCI IN CHILDREN WITH T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
por: Lizcova, L., et al.
Publicado: (2022)

Gene Expression Profiles Associated with Pediatric Relapsed AML
por: Bachas, Costa, et al.
Publicado: (2015)

Outcome of ALL With ALL-BFM-95 Protocol in Nepal
por: Sharma Poudyal, Bishesh, et al.
Publicado: (2023)

Molecular Measurable Residual Disease Assessment before Hematopoietic Stem Cell Transplantation in Pediatric Acute Myeloid Leukemia Patients: A Retrospective Study by the I-BFM Study Group
por: Benetton, Maddalena, et al.
Publicado: (2022)

Second malignant neoplasms after treatment of 1487 children and adolescents with acute lymphoblastic leukemia—A population‐based analysis of the Austrian ALL‐BFM Study Group
por: Poyer, Fiona, et al.
Publicado: (2022)

Long‐term treatment results of Polish pediatric and adolescent patients enrolled in the ALL IC‐BFM 2002 trial
por: Kowalczyk, Jerzy R., et al.
Publicado: (2019)

The impact of donor type on the outcome of pediatric patients with very high risk acute lymphoblastic leukemia. A study of the ALL SCT 2003 BFM-SG and 2007-BFM-International SG
por: Dalle, Jean-Hugues, et al.
Publicado: (2020)

The Response Regulator BfmR Is a Potential Drug Target for Acinetobacter baumannii
por: Russo, Thomas A., et al.
Publicado: (2016)

The sensor kinase BfmS controls production of outer membrane vesicles in Acinetobacter baumannii
por: Kim, Se Yeon, et al.
Publicado: (2019)

PB1747: OUTCOME OF CHILDHOOD ALLTREATED WITH ALL BFM IC 2009 PROTOCOL
por: Çilsaat, Gizem, et al.
Publicado: (2023)

Desiccation tolerance in Acinetobacter baumannii is mediated by the two-component response regulator BfmR
por: Farrow, John M., et al.
Publicado: (2018)

Genome-Wide Mapping Reveals Complex Regulatory Activities of BfmR in Pseudomonas aeruginosa
por: Fan, Ke, et al.
Publicado: (2021)

Incidence and Characteristics of Hypersensitivity Reactions to PEG-asparaginase Observed in 6136 Children With Acute Lymphoblastic Leukemia Enrolled in the AIEOP-BFM ALL 2009 Study Protocol
por: Rizzari, Carmelo, et al.
Publicado: (2023)

Identification of Fusion Gene Breakpoints is Feasible and Facilitates Accurate Sensitive Minimal Residual Disease Monitoring on Genomic Level in Patients With PML-RARA, CBFB-MYH11, and RUNX1-RUNX1T1
por: Lukes, Julius, et al.
Publicado: (2020)

Asparagine levels in the cerebrospinal fluid of children with acute lymphoblastic leukemia treated with pegylated-asparaginase in the induction phase of the AIEOP-BFM ALL 2009 study
por: Rizzari, Carmelo, et al.
Publicado: (2019)

PEG-asparaginase in BFM-90 regimen improves outcomes in adults with newly diagnosed lymphoblastic lymphoma
por: Zheng, Wen, et al.
Publicado: (2017)

Dose-adjusted EPOCH-rituximab or intensified B-non-Hodgkin lymphoma therapy for pediatric primary mediastinal large B-cell lymphoma. Results from the study B-NHL-BFM-04 and the NHL-BFM registry 2012
por: Knörr, Fabian, et al.
Publicado: (2021)

Relapses and treatment-related events contributed equally to poor prognosis in children with ABL-class fusion positive B-cell acute lymphoblastic leukemia treated according to AIEOP-BFM protocols
por: Cario, Gunnar, et al.
Publicado: (2020)

Cost-utility of Protocols of BFM-ALL and UK-ALL for Treatment of Children with Acute Lymphoblastic Leukemia in Iran
por: HAYATI, Hadi, et al.
Publicado: (2018)

InvBFM: finding genomic inversions from high-throughput sequence data based on feature mining
por: Wu, Zhongjia, et al.
Publicado: (2020)

Survival and prognostic analysis of T-cell lymphoblastic lymphoma patients treated with dose-adjusted BFM-90 regimen
por: Yu, Hui, et al.
Publicado: (2022)

Prediction of Antigenic Vaccine Peptide Candidates From BfmRS Associated With Biofilm Formation in Acinetobacter baumannii
por: Girija, A.S. Smiline
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_t7ajidn4q2h67fnhsri0cirqd5